Sophim, the sustainable cosmetic ingredients manufacturer, has completed a €20m funding round.
The total included €4.5m from Smalt Capital – the only financial investor in the round and a partner of Sophim since 2014 – as well as banking support and funding in recovery bonds.
The Peyruis, France-based company said the injection would enable it to double production capacity at its two industrial sites in Peyruis and Almeria, Spain.
It is also hoping to accelerate international growth with the aim of levelling-up from a small-to-medium-sized company to a mid-cap one.
“This investment will allow us to double our production capacity at our two industrial sites, to meet strong demand for our products, especially internationally,” said Sophim’s President, Jacques Margnat.
“Beyond purely financial criteria, the human, collective and ecological dimension occupies a central place in Sophim’s corporate culture,” added says Julien Jorge, manager at Smalt Capital.
“We are confident in the company’s ability to build on its competitive advantages to establish itself as a leader in its field.”
Founded in 1996, Sophim specialises in natural and renewable cosmetic ingredients; its flagship product is Phytosqualan, an olive-derived squalane that is 100% from vegetable origin.
Its products are distributed in more than 60 countries.
